Heck Capital Advisors, LLC Atri Cure, Inc. Transaction History
Heck Capital Advisors, LLC
- $1.47 Trillion
- Q4 2024
A detailed history of Heck Capital Advisors, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 1,955 shares of ATRC stock, worth $78,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,955Holding current value
$78,923% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
213Shares Held
49.6MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$186 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$160 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$114 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$113 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.87B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...